Nuwellis (NUWE) EPS (Diluted) Growth (1y) (2022 - 2026)
Nuwellis (NUWE) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 13.96% |
| 10 | Nuwellis | 208,429.45 | -3.71 Mn | 1.50 Mn | 56.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 98.75% |
| Mar 31, 2026 | 92.44% |
| Dec 31, 2025 | 92.45% |
| Sep 30, 2025 | -99.23% |
| Jun 30, 2025 | 92.30% |
| Mar 31, 2025 | 96.74% |
| Dec 31, 2024 | 99.22% |
| Sep 30, 2024 | 102.74% |
| Jun 30, 2024 | 85.14% |
| Mar 31, 2024 | 89.46% |
| Dec 31, 2023 | 54.45% |
| Sep 30, 2023 | 95.16% |
| Jun 30, 2023 | 91.30% |
| Mar 31, 2023 | 86.82% |
| Dec 31, 2022 | -102.89% |
| Sep 30, 2022 | 63.30% |
| Jun 30, 2022 | 54.70% |
| Mar 31, 2022 | 57.16% |